USPH
U.S. Physical Therapy, Inc.
NYSE: USPH · HEALTHCARE · MEDICAL CARE FACILITIES
$59.42
+2.72% today
Updated 2026-06-05
Market cap
$1.05B
P/E ratio
137.56
P/S ratio
1.33x
EPS (TTM)
$0.50
Dividend yield
2.73%
52W range
$58 – $92
Volume
0.2M
WallStSmart proprietary scores
52
out of 100
Grade: C
Hold
Investment rating
7.3
Growth
B+5.5
Quality
C+5.0
Profitability
C+3.3
Valuation
D3/9
Piotroski F-Score
Weak
2.2
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →203 stocks currently score above 75
Price targets
Analyst target
$93.67
+57.64%
12-Month target
$52.65
-11.39%
Intrinsic (DCF)
$85.88
Margin of safety
-2.63%
4 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 4.41%
- Negative free cash flow $-1.37M
- P/E 137.56x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $553.14M | $604.80M | $671.35M | $780.99M | $787.68M |
| Net income | $28.27M | $14.67M | $26.46M | $15.06M | $-4.33M |
| EPS | — | — | — | — | $0.50 |
| Free cash flow | $50.29M | $72.68M | $65.75M | $60.99M | $-1.37M |
| Profit margin | 5.11% | 2.43% | 3.94% | 1.93% | 4.41% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-09 | MINAN, PETER FRANCIS | Buy | 288 | $61.50 |
| 2026-06-08 | MINAN, PETER FRANCIS | Buy | 492 | $63.14 |
| 2026-05-19 | SWANSON, REGG E. | Buy | 2,306 | $61.61 |
Peer comparison
Smart narrative
U.S. Physical Therapy, Inc. trades at $59.42. representing a P/E of 137.56x trailing earnings. Our Smart Value Score of 52/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 2.22, it sits in the grey zone. TTM revenue stands at $787.68M. with profit margins at 4.41%. Our DCF model estimates intrinsic value at $85.88.
Frequently asked questions
What is U.S. Physical Therapy, Inc.'s stock price?
U.S. Physical Therapy, Inc. (USPH) trades at $59.42, on a P/E of 137.6x and a P/S of 1.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is U.S. Physical Therapy, Inc. overvalued?
U.S. Physical Therapy, Inc. carries a Smart Value Score of 52/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $85.88 against the $59.42 price, so on cash flow terms the market is paying a premium for U.S. Physical Therapy, Inc.'s growth. The Hold rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of U.S. Physical Therapy, Inc. (USPH)?
The 12-month analyst consensus target is $93.67, about 57.6% above the current $59.42. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the intrinsic value of U.S. Physical Therapy, Inc. (USPH)?
Our DCF model estimates intrinsic value at $85.88, a -2.6% margin of safety versus today's $59.42. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is U.S. Physical Therapy, Inc.'s revenue?
U.S. Physical Therapy, Inc.'s trailing twelve-month revenue is $787.68M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
U.S. Physical Therapy, Inc.'s Altman Z-Score is 2.22, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.33x
ROE0.25%
Beta1.16
50D MA$66.32
200D MA$77.40
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.2M
Performance
1 week+4.74%
1 month+3.35%
3 months-11.28%
YTD-15.07%
1 year—
3 years—
5 years—